The Russian Ministry of Health has announced the granting of a temporary use certificate, for the first Russian vaccine to treat the Coronavirus, an equivalent version of the Japanese vaccine Evigan.
According to Arabia Net, the vaccine named Avivavir was developed through a joint project between the Russian Direct Investment Fund (sovereign fund) and the ChemRar Group, which is designed To stop the virus from multiplying, it has already proven efficacy in clinical trials.
The head of the Russian sovereign fund, Kirill Dmitry, said in a statement that Avivavir is not only the first anti-Corona vaccine to be registered in Russia, but it could be the most vaccine and antiviral in the world. The world.
The investment fund provided 150 million rubles (about two million dollars) in financing the project.
The efficacy of this drug is more than 80%, thus showing better results compared to other drugs that have been tested in Russia and abroad.
The Russian health authorities announced, on Sunday, the registration of 9268 new cases of coronavirus during the past 24 hours, bringing the total to 405,842 thousand cases.
